The soluble biomarker calprotectin (a S100 protein) is associated to ultrasonographic synovitis scores and is sensitive to change in patients with rheumatoid arthritis treated with adalimumab
Hilde B Hammer*, Magne K Fagerhol, Tale N Wien and Tore K Kvien